- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
R&D Investment Reaches Record Levels
All patients -- whether fighting deadly diseases or managing long-term, chronic conditions -- live in the hope that tomorrow will bring the promise of new medicines and improved therapies. Research and development (R&D) is what makes such advancements possible.
America’s biopharmaceutical research companies invested a record $67.4 billion last year in the research and development of new life-changing medicines and vaccines – an increase of $1.5 billion from 2009, according to analyses by the Pharmaceutical Research and Manufacturers of America (PhRMA) and Burrill & Company.
Read the Full Press Release...
The Drug Discovery Process
We've all been touched by the miracles of modern medicine. But few people understand how medicines are made, and the immense effort required to get them to market and into our hands.
Resources
Despite the economic challenges of recent years, America's biopharmaceutical research companies remain a major source of employment in the United States.
